Skip to main content
Value8 N.V. logo

Value8 N.V. — Investor Relations & Filings

Ticker · VALUE ISIN · NL0010661864 LEI · 724500IOX980PF17L830 AS Financial and insurance activities
Open in API
Filings indexed 503 across all filing types
Latest filing 2012-05-11 Major Shareholding Noti…
Country NL Netherlands
Listing AS VALUE

About Value8 N.V.

https://www.value8.com/

Value8 N.V. is an investment company that focuses on acquiring and managing holdings in small and medium-sized companies. The firm specializes in various investment strategies, including middle-market buyouts, add-on acquisitions, and providing growth capital. Its primary objective is to achieve long-term value creation for its portfolio companies. Value8 maintains a diverse portfolio with investments in sectors such as healthcare services and equipment, IT business and cloud integration, and platforms for independent professionals.

Recent filings

Filing Released Lang Actions
Value8 vergroot belang in Fornix
Major Shareholding Notification Classification · 99% confidence The document is a short press release ("PERSBERICHT") dated May 11, 2012, announcing that Value8 NV increased its stake in Fornix BioSciences NV from 40.96% to 56.09% via open market purchases. This action constitutes a change in significant share ownership, crossing a threshold (likely 50% or a regulatory reporting threshold). This directly maps to the Major Shareholding Notification category (MRQ). Although it is a press release, the core content is the notification of a major shareholding change, making MRQ more specific than a general RPA or RNS.
2012-05-11 Dutch
Value8 doet bod op Fornix gestand
M&A Activity Classification · 99% confidence The document is a public announcement from Value8 N.V. regarding the outcome of a takeover bid for Fornix. It explicitly mentions the acceptance of the bid ('bod gestand') because the acceptance threshold (90%) was not met, but Value8 is waiving that condition. It details the number of shares tendered (10.96%) and the resulting ownership stake (40.96%). This content directly relates to a merger proposal or takeover bid, which aligns with the definition of M&A Activity (TAR). It is not a general earnings release, annual report, or a simple announcement of a report publication.
2012-05-07 Dutch
Annual Report 2011
Annual Report Classification · 100% confidence The document is titled 'JAARVERSLAG 2011' (Annual Report 2011) for Value8 N.V. It contains a comprehensive review of the company's activities, financial highlights, management reports, and governance information for the fiscal year 2011. It is a full-length annual report, not an announcement or a summary. FY 2011
2012-04-30 Dutch
Aandeel Value8 vanaf 30 april in continue handel
Share Issue/Capital Change Classification · 99% confidence The document announces several corporate actions: the transition of the common share trading from auction to continuous trading starting April 30, 2012, which is a structural change related to the stock listing/trading mechanism. It also mentions that the Extraordinary General Meeting of Shareholders (BAVA) approved an authorization for share issuance, and it states that the 2011 Annual Report will be made available on the website on April 30. Since the document is short (1444 chars) and primarily announces future availability of a report ('Het jaarverslag 2011 zal op 30 april a.s. op de website beschikbaar worden gesteld') rather than containing the full report itself, it fits the criteria for a Report Publication Announcement (RPA). The primary focus, however, is the trading mechanism change, which is a capital/financing structure event, but the explicit mention of the report publication makes RPA a strong candidate, or potentially SHA/CAP if the focus was solely on the issuance authorization. Given the explicit mention of the report release date, RPA is the most precise fit based on Rule 2 (Menu vs Meal).
2012-04-27 Dutch
Goede resultaten Value8 over 2011
Earnings Release Classification · 99% confidence The document is titled "PERSBERICHT" (Press Release) and summarizes the financial results for the full year 2011 (Omzet, Nettowinst, Winst per aandeel, Eigen vermogen). It provides key financial highlights and outlook for 2012. This structure strongly indicates an initial announcement of periodic financial results, which aligns with the definition of an Earnings Release (ER). Although it mentions the results are derived from the 'gecontroleerde jaarrekening' (audited annual accounts) and that the full annual report will be published later, the document itself is the summary announcement, not the comprehensive 10-K or AR. The document length (4528 chars) is consistent with a summary release rather than a full annual report. FY 2011
2012-04-20 Dutch
Value8 neemt belang van 5,32 procent in Euromedis
Major Shareholding Notification Classification · 99% confidence The document is a press release ("PERSBERICHT") dated April 4, 2012, announcing that Value8 NV has acquired a 5.32% stake in Euromedis Groupe. The text explicitly mentions that a notification was made to the French stock regulator (AMF) because the 5 percent threshold was crossed. This action—reporting a change in significant share ownership that crosses a regulatory threshold—directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a press release, the core subject matter is the mandatory disclosure of a significant ownership change.
2012-04-04 Dutch

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.